About Shruti Drugs
Shruti Drugs is a company based in Secunderabad (India) founded in 1992. It operates as a SaaS and B2B. Shruti Drugs offers products and services including WebMail Client, Web Administration Portal, Exchange ActiveSync, Mobile Calendaring (CalDAV), and Mobile Contacts (CardDAV). Shruti Drugs operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Secunderabad, India
-
Sectors
Technology
-
Phone
Locked
-
Website
Locked
- Legal Name Shruti Drugs Private Limited
- Date of Incorporation 11 Jul, 1994
- Jurisdiction Secunderabad, Telangana, India
-
Annual Revenue
$5.03 M (USD)62.62as on Mar 31, 2023
-
Net Profit
$71.65 K (USD)96.68as on Mar 31, 2023
-
EBITDA
$306.71 K (USD)186.16as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Shruti Drugs
Shruti Drugs offers a comprehensive portfolio of products and services, including WebMail Client, Web Administration Portal, Exchange ActiveSync, Mobile Calendaring (CalDAV), and Mobile Contacts (CardDAV).
Enables mailbox access via desktop and mobile web browsers.
Allows creation and management of mailboxes through web browsers.
Supports ActiveSync protocol for mobile device email access.
Facilitates remote access to mailbox calendars on devices.
Enables remote access and synchronization of mailbox contacts.
Allows sharing and access to public calendar files via HTTP.
Provides integration for Microsoft Outlook on desktops.
Synchronizes contacts, calendars, and tasks with MailEnable accounts.
Funding Insights of Shruti Drugs
Detailed funding history for Shruti Drugs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Shruti Drugs
Investment portfolio details for Shruti Drugs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Shruti Drugs
Detailed financials for Shruti Drugs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Shruti Drugs Comparisons
Peer comparison for Shruti Drugs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Shruti Drugs
Shruti Drugs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Shruti Drugs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Shruti Drugs
Complete news archive for Shruti Drugs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shruti Drugs
Shruti Drugs was founded in 1992.
Shruti Drugs is headquartered in Secunderabad, India. It is registered at Secunderabad, Telangana, India.
Annual revenue of Shruti Drugs is $5.03M as on Mar 31, 2023.
MailEnable is a software service that enables users to access and manage email mailboxes through web browsers on desktops and mobile devices. It supports features like ActiveSync for mobile synchronization, CalDAV for calendaring, CardDAV for contacts, and ICS sharing for calendar access. The platform allows users to administer mailboxes and synchronize contacts, calendars, and tasks via HTTP requests, catering to individuals and businesses without specified locations or clients.
Shruti Drugs's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Shruti Drugs offers WebMail Client, Web Administration Portal, Exchange ActiveSync, Mobile Calendaring (CalDAV), and 4 more products and services.